Neuroblastoma is one of the most common solid cancers in children, and is associated with a poor prognosis in advanced cases.
Cannabinoids have been found to show positive effects on cancer, and work in a variety of ways to create those effects. In this study, the 2 most common components of marijuana (cannabis), THC and CBD, were evaluated for their anti neuroblastoma effects both in vitro (laboratory setting) and in vivo (in a biological organism).
In the laboratory setting both THC and CBD demonstrated anti-tumorigenic activity, and both impeded growth of tumor grafts in vivo. Treatment with CBD reduced invasiveness of treated tumor cells and induced tumor cell death.
Of these 2 common marijuana components, CBD was the more active in anti-tumor activity. Overall, marijuana continues to impress in its potential as a broad spectrum natural medicine.
